AKYA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AKYA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Akoya Biosciences's change in inventory for the quarter that ended in Mar. 2024 was $-7.31 Mil. It means Akoya Biosciences's inventory increased by $7.31 Mil from Dec. 2023 to Mar. 2024 .
Akoya Biosciences's change in inventory for the fiscal year that ended in Dec. 2023 was $-6.33 Mil. It means Akoya Biosciences's inventory increased by $6.33 Mil from Dec. 2022 to Dec. 2023 .
Akoya Biosciences's Total Inventories for the quarter that ended in Mar. 2024 was $22.99 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Akoya Biosciences's Days Inventory for the quarter that ended in Mar. 2024 was 186.99.
Inventory Turnover measures how fast the company turns over its inventory within a year. Akoya Biosciences's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.49.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Akoya Biosciences's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.11.
The historical data trend for Akoya Biosciences's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akoya Biosciences Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Change In Inventory | -4.01 | -0.68 | -4.63 | -5.37 | -6.33 |
Akoya Biosciences Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Inventory | Get a 7-Day Free Trial | -0.14 | -3.91 | -3.00 | 0.71 | -7.31 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akoya Biosciences (NAS:AKYA) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Akoya Biosciences's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 20.4325 | / | 9.971 | * | 365 / 4 | |
= | 186.99 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Akoya Biosciences's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 9.971 | / | 20.4325 | |
= | 0.49 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Akoya Biosciences's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 20.4325 | / | 18.35 | |
= | 1.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Akoya Biosciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Brian Mckelligon | director, officer: President/CEO | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01752 |
Frederic Pla | officer: Chief Operating Officer | C/O GENOMIC HEALTH, INC., 101 GALVESTON DRIVE, REDWOOD CITY CA 94063-4700 |
Goldman Myla Lai | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
John Frederick Ek | officer: Chief Financial Officer | 5964 LA PLACE COURT, CARLSBAD CA 92008 |
Scott Mendel | director | 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008 |
Matthew Winkler | director | C/O MIRNA THERAPEUTICS, INC., 2150 WOODWARD ST., SUITE 100, AUSTIN TX 78744 |
Thomas A. Raffin | director, 10 percent owner | C/O NEWLINK GENETICS CORP., 2503 SOUTH LOOP DR., SUITE 5100, AIMES IA 50010 |
Robert G Shepler | director | |
Jennifer Kamocsay | officer: General Counsel | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01762 |
Joseph Driscoll | officer: Chief Financial Officer | 5 DICARLO ROAD, HOPKINTON MA 01748 |
Nolan Garry Ph.d. | director | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01752 |
Thomas P Schnettler | director | 800 NICOLLET MALL, J1012057, MINNEAPOLIS MN 55402-7020 |
Ehab El-gabry | officer: Chief Medical Officer | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01752 |
Marilee Moy | officer: Chief People Officer | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01752 |
Ramachandran Niro Ph.d | officer: Chief Business Officer | 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH MA 01752 |
From GuruFocus
By Tiesvg Tiesvg • 12-28-2022
By sperokesalga sperokesalga • 06-08-2023
By Marketwired • 10-17-2023
By GuruFocus Research GuruFocus Editor • 02-17-2023
By sperokesalga sperokesalga • 02-28-2023
By GuruFocus Research • 06-13-2023
By Marketwired • 07-26-2023
By Marketwired • 11-02-2023
By Stock market mentor Stock market mentor • 02-06-2023
By Stock market mentor Stock market mentor • 02-01-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.